Print page Close print preview
Logo Going International
Accedi a banche dati online | Convegnodetail
 

Tumor Myeloid Microenvironment Directed Therapeutics Summit 2021

Evvnt Promotion / evvnt
Archivio
-
16.03.2021 - 18.03.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temi della conferenza
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/701752-3?pid=4832

Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/701752-0?pid=4832
Ms. Aarti Diwan
 
Categorie
Medicina General, Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 1499.00 - USD 2997.00
I partecipanti attesi
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom